NSE / BSEHealthcare
₹215.45-0.80-0.37%
P/E257.0Mkt Cap₹2.62 K CrEV/EBITDA12.1

Hikal Ltd.

P/E257.0Mkt Cap₹2.62 K CrEV/EBITDA12.1
Company Profile

Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, biotechnology, life sciences, animal health, crop protection, and specialty chemicals indusries. It operates through two segments, Pharmaceuticals and Crop Protection. The company also manufactures pesticides and herbicides, which include diuron tech, temephos tech, thiacloprid tech, clothianidin tech, dichloroaniline, N-bromosuccinimide, prothioconazole technical, trifloxystrobin technical, and BIT. In addition, it offers solutions in contract research, custom synthesis, and custom manufacturing of intermediates and active ingredients. Further, the company provides anti-convulsant, anti-inflammatory, analgesic, Anti-parasitic, anti-lipemic, anti-histaminic, anti-depressant, anti-psychotic, anti-emetic, anti-diabetic, anti-thrombotic, Anti-viral, anti-hypertensive, and Haemorheologic; animal health products, such as anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone, insecticide, and NSAID; and specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company also exports its products. It operates in India, the United States, Canada, Europe, South East Asia, and internationally. The company was formerly known as Hikal Chemical Industries Ltd. and changed its name to Hikal Limited in April 2000. Hikal Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.

Valuation

Market Cap
₹0.00
Current Price
₹0
as of 16 Oct 2026
P/E Ratio
0.0x
P/B Ratio
0.0x
EV / EBITDA
0.0x
EV / Sales
0.0x
52W High
₹0
52W Low
₹0
Shares Out
0.00 Cr

Profitability

Operating Margin
0.0%
Net Profit Margin
0.0%
EBITDA Margin
0.0%

Returns

ROE
0.0%
ROCE
0.0%
ROIC %
—
ROA
0.0%
Dividend Payout
0.0%

Solvency

Current Ratio
0.0x
Debt / Equity
0.0x
Debt / Assets
0.0x
CFO / Net Profit
0.0x
Interest Coverage
0.0x

AI Summary

Indian Stock

Strengths1

  • Maintains healthy dividend payout of 21.0%

Concerns1

  • Low return on equity of 5.9%

Rule-based from financial data. Not advice.

Price History▼ 10.27% over 1Y

Monthly Returns

Unlock Monthly Returns

Available on Pro and Institutional plans.

Sign up free

Year-to-Date ROI

Unlock Year-to-Date ROI

Available on Pro and Institutional plans.

Sign up free

Historical Volatility

Unlock Historical Volatility

Available on Pro and Institutional plans.

Sign up free

Historical Performance

Revenue, profitability, and cash flow trends (₹ Crores)

Revenue (10Y)

Operating Income (10Y)

Net Profit (10Y)

Operating Margin % (10Y)

Dividend Payout % (10Y)

Free Cash Flow (10Y)

Growth Summary

Latest fiscal year: Mar 2025

Revenue₹1.86 K Cr▲ 4.2%
EBITDA Growth—
Net Profit₹91.00 Cr▲ 30.0%
Cash from Ops (CFO)—
Free Cash Flow (FCF)—▼ 100.0%
Revenue CAGR 5Y3.4%
EBITDA CAGR 5Y0.6%
Net Profit CAGR 5Y-3.6%
NP Growth 1Y30.0%

Historical Growth

Year-by-year revenue, profitability, and cash flow (₹ Crores, last 1 year)

YearRevenueOp. IncomeNet ProfitCFOFCFROERev Growth 1YNP Growth 1Y
Mar 2025₹1.86 K Cr—₹91.00 Cr——7.2%4.2%30.0%

Showing the latest year only. Sign up free for the full history.

Financial Statements

Income statement, balance sheet, and cash flow (₹ Crores, as reported)

Showing the latest year only. Sign up free for the full history.

Consolidated Figures in USD Millions.

Unnamed: 0TTM
Revenue / Net Sales1,699
Total Expenses1,471
EBIT / Operating Profit228
OPM %13%
Other Income7
Finance Costs69
Depreciation & Amortisation152
Profit Before Tax15
Tax %-
Net Profit / PAT10
EPS (₹)0.83
Dividend Payout %-

Peer Comparison

Healthcare sector peers, ranked by market cap

CompanyMarket CapRevenueP/EP/BEV/EBITDARev G 1Y
Hikal Ltd.this co.₹2.62 K Cr₹1.86 K Cr257.002.2012.054.2%
Sun Pharmaceutical Industries Ltd.₹4.15 L Cr₹23.00 K Cr88.7017.4372.3013.5%
Divi's Laboratories Ltd.₹1.71 L Cr₹9.20 K Cr67.9011.1367.2120.0%
Torrent Pharmaceuticals Ltd.₹1.33 L Cr₹9.68 K Cr62.5015.7645.6413.5%
Cipla Ltd.₹1.17 L Cr₹19.05 K Cr22.503.5119.3314.9%
Apollo Hospitals Enterprises Ltd.₹1.05 L Cr₹8.20 K Cr75.0011.2854.4412.8%
Max Healthcare Institute Limited₹1.00 L Cr₹2.66 K Cr144.0011.7696.8413.8%
Industry Average—₹3.29 K Cr98.638.1165.5020.2%

Learn while you research

Hand-picked academy chapters to deepen your understanding of Hikal Ltd. and the metrics that matter.

Browse the full Equiscale Academy